Patent details

301119 Product Name: Selinexor of een farmaceutisch aanvaardbaar zout ervan

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
301119
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP2736887
Status:
SPC granted but not yet in force
Application number:
301119
Procedural language:
Dutch
First Applicant Residence Country:
United States of America (US)

Marketing Authorization

Marketing Authorization Number:
EU/1/21/1537
Marketing Authorization Type:
EEA
Marketing Authorization Date:
29/03/2021
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
30/07/2021
First Marketing Authorization date:
29/03/2021
Grant date:
15/09/2021
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
02/08/2021
SPC/SPC Extension Expiration Date:
28/03/2036
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
07/08/2023
 
 

 

Name:
Karyopharm Therapeutics Inc.
Address:
85 Wells Avenue, 2nd Floor, 02459, Newton, Massachusetts, United States of America (US)

Historical Applicant/holder

From:
30/07/2021
To:
07/08/2023

 

Name:
Karyopharm Therapeutics, Inc.
Address:
85 Wells Avenue, 2nd Floor, 02459, Newton, Massachusetts, United States of America (US)

Agent

Name:
ir. M.F.J.M. Ketelaars c.s.
From:
30/07/2021
Address:
NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:

Publication

Bulletin

1

Bulletin Heading:
CO
Journal edition number:
33/23
Publication date:
16/08/2023
Description:
Changes in the Netherlands Patent Register

2

Bulletin Heading:
SPC
Journal edition number:
38/21
Publication date:
22/09/2021
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

3

Bulletin Heading:
SPC
Journal edition number:
31/21
Publication date:
04/08/2021
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of owner(s) name
Deed Number:
RC202301613A
Date Registered:
07/08/2023
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
dr. R.C. van Duijvenbode c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
Karyopharm Therapeutics Inc.
Address:
85 Wells Avenue, 2nd Floor, 02459, Newton, Massachusetts, United States of America (US)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
31/07/2032
Annual Fee Number:
21
Annual Fee Amount:
1600 Euro
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Document Description Number of pages File Type
15/09/2021 Outgoing Correspondence Decision grant 1 PDF /3/7/7/8/0/0800708773/docs/301119_1_435729l504a.pdf
15/09/2021 Certificate Certificate 1 PDF /3/7/7/8/0/0800708773/docs/301119_7_spcmedcertificate20210915130711184.pdf
02/08/2021 Outgoing Correspondence Confirmation receipt request 1 PDF /3/7/7/8/0/0800708773/docs/301119_2_426899l174.pdf
30/07/2021 SPC Documents Accompanying letter SPC 1 PDF /3/7/7/8/0/0800708773/docs/301119_0_supplprotectioncertificate20210802115412256.pdf
30/07/2021 SPC Documents Marketing Authorization SPC 3 PDF /3/7/7/8/0/0800708773/docs/301119_3_supplprotectioncertificate20210802115456079.pdf
30/07/2021 Application Form First filed application form 2 PDF /3/7/7/8/0/0800708773/docs/301119_4_applicationform20210802115227477.pdf
30/07/2021 SPC Documents Summary of the characteristics of the product 17 PDF /3/7/7/8/0/0800708773/docs/301119_5_supplprotectioncertificate20210802115648708.pdf
30/07/2021 SPC Documents Annex SPC 2 PDF /3/7/7/8/0/0800708773/docs/301119_6_supplprotectioncertificate20210802115520948.pdf